<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548661</url>
  </required_header>
  <id_info>
    <org_study_id>CTO Project ID: 2123</org_study_id>
    <nct_id>NCT04548661</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation</brief_title>
  <official_title>Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation: A Vanguard Randomized Controlled Trial (CLEAN Wound)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Following a surgical procedure, patients may experience complications, such as a surgical&#xD;
      site infection (SSI). The Centers for Disease Control and Prevention (CDC) define a SSI as an&#xD;
      incisional or organ space infection which occurs following a surgical procedure. The severity&#xD;
      is then classified as a superficial, deep or organ space infection, occurring within 30 days&#xD;
      of surgery. Despite improvements in patient care and a variety of available preoperative,&#xD;
      intraoperative and postoperative infection prevention strategies, SSIs still occur very&#xD;
      frequently. They account for 20% of hospital infections and are associated with important&#xD;
      economic and patient outcomes such as morbidity, mortality and length of stay. It is&#xD;
      estimated that over half (55%) of SSIs could be prevented. One proposed intervention to&#xD;
      reduce SSIs is the intraoperative irrigation of incisional wounds. By washing a solution over&#xD;
      an open wound, debris, bacteria and bodily fluids may be removed prior to wound closure at&#xD;
      the end of a procedure. Although many studies have been conducted, uncertainty remains with&#xD;
      respect to the following: 1) the need for irrigation; 2) the solution used to irrigate; 3)&#xD;
      the method of irrigation (i.e. pour, syringe, pressure and/or pulsed delivery); and 4) the&#xD;
      volume of irrigation, leading to conflicting guidelines and practice heterogeneity. In this&#xD;
      trial, adult patients scheduled to undergo an elective abdominal open or laparoscopic&#xD;
      procedure will be randomly assigned to incisional wound irrigation with povidone-iodine&#xD;
      solution; or incisional wound irrigation with saline; or no irrigation. This trial will be&#xD;
      conducted under the IMPACTS (Innovative, Multicentre, Patient-centred Approach to Clinical&#xD;
      Trials in Surgery) program umbrella and will follow IMPACTS methodology. For the Vanguard&#xD;
      trial, the aim is to determine the feasibility of conducting a definitive trial. Future&#xD;
      outcomes of interest include surgical site infection and quality of life, among others.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background/Rationale: Recent international Guidelines and reviews have highlighted that&#xD;
      studies of intraoperative irrigation are small, outdated (i.e., no longer reflect current&#xD;
      standards of care), and judged to be of very low to moderate quality, and have called for&#xD;
      additional RCTs. For example, as per the WHO Guidelines, RCTs are needed to assess frequently&#xD;
      utilized irrigation solutions and their effect on SSI and state that a suitable alternative&#xD;
      to povidone-iodine is currently unknown. Furthermore, determining whether irrigation with&#xD;
      antiseptics and antibiotics can reduce SSIs was listed as a key research recommendation by&#xD;
      NICE, in addition to determining cost-effectiveness of the intervention. Further evidence is&#xD;
      required to support or refute the effectiveness of intraoperative irrigation in reducing SSIs&#xD;
      and to address practice heterogeneity, with a focus on establishing whether irrigation is&#xD;
      needed, and if so, which solution is optimal for this practice. We aim to address this&#xD;
      knowledge gap by assessing the benefit of intraoperative wound irrigation with&#xD;
      povidone-iodine solution as compared to with saline, or no irrigation in adults aged 18 years&#xD;
      or older who are scheduled to undergo an elective abdominal surgery.&#xD;
&#xD;
      Objectives: Before embarking on a definitive RCT, this pilot trial has five specific&#xD;
      feasibility objectives:&#xD;
&#xD;
        1. To assess our ability to accrue patients using the IMPACTS Program design platform at&#xD;
           multiple institutions, over the course of one year.&#xD;
&#xD;
        2. To assess our ability to adaptively randomize patients and deliver the randomized&#xD;
           assignment using the IMPACTS Program design platform, over the course of one year.&#xD;
&#xD;
        3. To assess our ability to collect complete data directly from participants (patients and&#xD;
           clinicians) on: surgical site infection and quality of life over the course of one year.&#xD;
&#xD;
        4. To examine our ability to carry out data linkages using the IMPACTS Program design&#xD;
           platform over the course of one year.&#xD;
&#xD;
        5. To estimate the rate of surgical site infections to inform the sample size calculation&#xD;
           for the definitive trial.&#xD;
&#xD;
      Study design: This is a multicenter, pragmatic, open-label, 3-arm Vanguard RCT. Participants&#xD;
      will be randomized using an adaptive design to incisional wound irrigation with&#xD;
      povidone-iodine versus incisional wound irrigation with saline versus no irrigation.&#xD;
      Participants will be followed until 30 days after surgery to assess the incidence of SSIs,&#xD;
      with additional outcomes collected until 90 days after surgery. If feasibility is&#xD;
      demonstrated during the pilot trial, we will plan to conduct a definitive trial. If there are&#xD;
      only minimal changes to the protocol, we will include data from the pilot phase into the&#xD;
      definitive trial analysis (i.e. a Vanguard design).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 5, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Pragmatic, multicentre, open-label, three-arm Vanguard randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of accrual (one year)</measure>
    <time_frame>1 year</time_frame>
    <description>Average number of patients enrolled per month across multiple sites for the trial: feasible if 10 or more overall.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability to deliver the intervention that the participant is randomized to receive</measure>
    <time_frame>1 year</time_frame>
    <description>Feasible if &gt;90% of participants receive the correct intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability to collect complete data for patient-reported outcomes</measure>
    <time_frame>1 year</time_frame>
    <description>Feasible if &gt;80% of data is collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability to link data from patient-reported outcome measures with Institute for Clinical Evaluative Sciences (ICES) and National Surgical Quality Improvement Program (NSQIP) datasets</measure>
    <time_frame>1 year</time_frame>
    <description>Feasible if linkage is possible in &gt;90% of participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimation of surgical site infections (SSIs)</measure>
    <time_frame>1 year</time_frame>
    <description>Number of SSIs within 30 days of surgery in each group</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Povidone-iodine solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No irrigation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard incision management</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraoperative incisional wound irrigation with povidone-iodine solution</intervention_name>
    <description>Participants will have the open incision or laparoscopic extraction site irrigated once with povidone-iodine diluted in 0.9% sterile normal saline (to a final concentration of 5% povidone-iodine (0.5% available iodine)) delivered through a bulb syringe. The povidone-iodine irrigation should be left on for 60 seconds and then dried with sterile gauze. Irrigation will be performed after any/all deep tissue layers are closed, prior to skin closure. The volume used will be left to the discretion of the clinician and irrigation will be administered until saturation is achieved.</description>
    <arm_group_label>Povidone-iodine solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraoperative incisional wound irrigation with saline</intervention_name>
    <description>Participants will have the open incision or laparoscopic extraction site irrigated once with 0.9% sterile normal saline delivered through a bulb syringe. Irrigation will be performed after any/all deep tissue layers are closed, prior to skin closure. The volume used will be left to the discretion of the clinician and irrigation will be administered until saturation is achieved.</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults aged 18 years or older;&#xD;
&#xD;
          2. Scheduled to undergo an open or laparoscopic elective procedure with a planned&#xD;
             extraction site â‰¥3 cm;&#xD;
&#xD;
          3. Surgical procedure considered to be a laparotomy or have a groin incision; and&#xD;
&#xD;
          4. Anticipated CDC wound classification I (clean), II (clean-contaminated) or III&#xD;
             (contaminated).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Laparoscopic procedures without a planned extraction site;&#xD;
&#xD;
          2. Known or anticipated CDC wound classification IV (dirty); and&#xD;
&#xD;
          3. Contraindication to receiving povidone-iodine irrigation (i.e. known allergy).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Karanicolas, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erin Lillie, MSc</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>87534</phone_ext>
    <email>erin.lillie@sunnybrook.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Roke, BSc (Hons)</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>85391</phone_ext>
    <email>rachel.roke@sunnybrook.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>North York General Hospital</name>
      <address>
        <city>North York</city>
        <state>Ontario</state>
        <zip>M2K 1E1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Smith, MD MSc</last_name>
      <phone>(416) 498-8458</phone>
      <email>davidsmith@nygh.on.ca</email>
    </contact>
    <investigator>
      <last_name>David Smith, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jad Abou-Khalil, MD MSc</last_name>
      <phone>613-737-8899</phone>
      <phone_ext>71053</phone_ext>
      <email>jaboukhalil@toh.ca</email>
    </contact>
    <investigator>
      <last_name>Jad Abou-Khalil, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Karanicolas, MD PhD</last_name>
      <phone>416-480-4774</phone>
      <email>paul.karanicolas@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Paul Karanicolas, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnybrook Health Sciences Centre</investigator_affiliation>
    <investigator_full_name>Dr. Paul Karanicolas</investigator_full_name>
    <investigator_title>Scientist</investigator_title>
  </responsible_party>
  <keyword>Intraoperative incisional wound irrigation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

